629 filings
Page 3 of 32
8-K
d46qwed
9 Jan 23
Regulation FD Disclosure
6:03am
8-K
dfbvadja
2 Nov 22
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
6:05am
8-K
uc906
11 Oct 22
United Therapeutics Announces First Patient Enrolled In Phase 3 Teton 2 Study of Tyvaso In Patients with Idiopathic Pulmonary Fibrosis
7:15am
8-K
j929wmn5 vly0
20 Sep 22
Other Events
6:00am
8-K
ya9bdz
1 Sep 22
United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation
6:01am
UPLOAD
e2cnrkks
10 Aug 22
Letter from SEC
12:00am
CORRESP
eb83tohb efjm8
9 Aug 22
Correspondence with SEC
12:00am
S-8
sab6fk45gnkh8jtelvzv
3 Aug 22
Registration of securities for employees
7:01am
8-K
1xqtxzm1fc dhst
3 Aug 22
United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
6:06am
UPLOAD
a9bf0x
19 Jul 22
Letter from SEC
12:00am
UPLOAD
giku9y1d
14 Jul 22
Letter from SEC
12:00am
8-K
5q7ym5c weq0h2moge
28 Jun 22
Departure of Directors or Certain Officers
5:08pm
SD
b9yaql7v30hen
31 May 22
Conflict minerals disclosure
4:30pm
8-K
05k13a 8c9uqoeh0t7o
24 May 22
First approval of a dry powder inhaler for treatment of PAH and PH-ILD
6:01am
8-K
mbxdpfcixp3kniy1lm
4 May 22
United Therapeutics Corporation Reports First Quarter 2022 Financial Results
6:08am
DEFA14A
yglbgb hxfby82gr
29 Apr 22
Additional proxy soliciting materials
6:01am